A high-adiponectin-to-low-chemerin ratio is suggested to play an important role in the development of metabolic syndrome in obesity, and this might be a target of therapeutic interventions meant to treat infertility in obese males [56]. Here, ADIPOQ is linked to metabolic syndrome.